ISSN 1662-4009 (online)

ey0019.9-15 | Bone health in chronic disease | ESPEYB19

9.15. Bone health in pediatric patients with Crohn disease

S Rozes , S Guilmin-Crepon , M Alison , E Thomas , JP Hugot , J Viala , C Martinez-Vinson

christine.martinez-vinson@aphp.fr J Pediatr Gastroenterol Nutr. 2021; 73: 231-235. PMID: 33908740.Brief Summary: This retrospective study evaluated longitudinal changes in bone mineral density (BMD) in children and adolescents with Crohn disease (CD), and the risk factors for low BMD. Low BMD (defined as BMD Z score ≤ -2.0) was present in 18.7% of patients at diagnosis and in 16% at ...

ey0021.5-4 | Advances in Clinical Practice | ESPEYB21

5.4. Serum phosphorus as a driver of skeletal morbidity in fibrous dysplasia

Hasan Gun Zubeyir , Osamor Charles , Taylor Jocelyn , Li Xiaobai , Szymczuk Vivian , Boyce Alison M.

In brief: This retrospective study reports on the relationship between serum phosphorus and fibrous dysplasia-related skeletal complications (fractures, orthopaedic surgery, and scoliosis) in a large cohort of patients (n=240).Commentary: Fibrous dysplasia (FD) / McCune-Albright syndrome (MAS) is a rare mosaic disorder caused by postzygotic gain-of-function mutations in Gαs, resulting in continuous receptor activation. FD can range from an isolated,...

ey0021.5-8 | Novel Treatments | ESPEYB21

5.8. Management of RANKL-mediated disorders with denosumab in children and adolescents: a global expert guidance document

Vanderniet Joel A. , Szymczuk Vivian , Hogler Wolfgang , Beck-Nielsen Signe S. , Uday Suma , Merchant Nadia , Crane Janet L. , Ward Leanne M. , Boyce Alison M. , Munns Craig F.

In brief: This article reviews the evidence and provides expert opinion on the safe and appropriate use of denosumab in children and adolescents with RANKL-mediated disorders such as giant cell bone tumours, fibrous dysplasia and juvenile Paget’s disease.Commentary: Receptor activator of nuclear factor κB ligand (RANKL) is expressed by osteogenic cells and induces osteoclast differentiation by binding to RANK on osteoclast precursors. Excessive...